Share

June 12, 2012; 78 (24) Special Article

Evidence-based guideline update: Medical treatment of infantile spasms

Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

C.Y. Go, M.T. Mackay, S.K. Weiss, D. Stephens, T. Adams-Webber, S. Ashwal, O.C. Snead
First published June 11, 2012, DOI: https://doi.org/10.1212/WNL.0b013e318259e2cf
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
20167

Share

Article Information

vol. 78 no. 24 1974-1980
DOI: 
https://doi.org/10.1212/WNL.0b013e318259e2cf
PubMed: 
22689735
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received January 10, 2012
  • Accepted March 19, 2012
  • First Published June 11, 2012.
Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. C.Y. Go, MD,
    2. M.T. Mackay, MBBS, FRACP,
    3. S.K. Weiss, MD, FRCPC,
    4. D. Stephens, MSc,
    5. T. Adams-Webber, MLS,
    6. S. Ashwal, MD, FAAN and
    7. O.C. Snead III, MD FAAN
  1. C.Y. Go, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. M.T. Mackay, MBBS, FRACP,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. S.K. Weiss, MD, FRCPC,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. D. Stephens, MSc,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. T. Adams-Webber, MLS,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. S. Ashwal, MD, FAAN and
    7. Scientific Advisory Boards:

    1. SITT trial DSMB member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. PEDIATRIC NEUROLOGY

    Patents:

    1. NONE

    Publishing Royalties:

    1. PEDIATRIC NEUROLOGY (JOURNAL) PEDIATRIAC NEUROLOGY:PRINICPLES AND PRACTICE; -- COEDITOR

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Ongoing Research Support (OSR# 56232) S. Ashwal (PI) 2006- 2011 NIH-04-298 Phase II Multi-Center Study of Rapamycin for Treating Kidney Angiomyolipomas in TSC or LAM Patients. This study investigates the use of Rapamycin for the treatment of kidney angiomyolipomas in patients with tuberous sclerosis or lymphangioleiomyomatosis. Role: Principal Investigator (OSR# 56077) S. Ashwal (PI) 2006- 2011 NINDS--R01 NS054001-01 Pediatric TBI and DAI: Normal Appearing Brain is not Normal This prospective 5-yr study will use SWI, MRI and MRS in 90 pediatric TBI and 90 controls to determine which specific imaging variables will predict outcome. Role: Principal Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. O.C. Snead III, MD FAAN
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Hospital for Sick Children and University of Toronto. Faculty of Medicine (C.Y.G., S.K.W., D.S., T.A.-W., O.C.S.), Toronto, Canada; Royal Children's Hospital (M.T.M.), Melbourne, Australia; and Loma Linda University School of Medicine (S.A.), Loma Linda, CA.
  1. Correspondence & reprint requests to American Academy of Neurology: guidelines{at}aan.com
View Full Text

Article usage

Article usage: June 2012 to November 2019

AbstractFullPdfSource
Jun 201224403401524Highwire
Jul 2012567413992Highwire
Aug 2012234237555Highwire
Sep 2012137220625Highwire
Oct 2012125490936Highwire
Nov 2012107191602Highwire
Dec 2012100165499Highwire
Jan 201375179568Highwire
Feb 201398176459Highwire
Mar 201371138312Highwire
Apr 2013120161299Highwire
May 2013116107243Highwire
Jun 201392100226Highwire
Jul 201393126271Highwire
Aug 2013119117259Highwire
Sep 20138489232Highwire
Oct 2013129121264Highwire
Nov 201371148225Highwire
Dec 201389184178Highwire
Jan 201474300151Highwire
Jan 201406838pmc
Feb 201449306185Highwire
Mar 201469350207Highwire
Apr 201478293185Highwire
May 201464425315Highwire
Jun 201458260136Highwire
Jul 201476309135Highwire
Aug 201456294142Highwire
Sep 201464251154Highwire
Oct 201479296143Highwire
Nov 201460281167Highwire
Dec 201458227126Highwire
Jan 201569281141Highwire
Jan 201506246pmc
Feb 201574282140Highwire
Feb 201508048pmc
Mar 201572261147Highwire
Mar 201508552pmc
Apr 201555258123Highwire
Apr 2015010048pmc
May 201553315147Highwire
May 201505428pmc
Jun 201536273167Highwire
Jun 201507833pmc
Jul 201563257119Highwire
Jul 201508450pmc
Aug 201542340145Highwire
Aug 201505233pmc
Sep 201572349158Highwire
Sep 201508931pmc
Oct 201564323111Highwire
Oct 201507732pmc
Nov 201563353129Highwire
Nov 201508238pmc
Dec 201546320106Highwire
Dec 201505919pmc
Jan 201666369148Highwire
Jan 201609246pmc
Feb 201656271158Highwire
Feb 201605724pmc
Mar 201680286149Highwire
Mar 201608344pmc
Apr 201679256112Highwire
Apr 201607648pmc
May 2016189271148Highwire
May 201608135pmc
Jun 201658299149Highwire
Jun 201606744pmc
Jul 201648230132Highwire
Jul 201604618pmc
Aug 201644288133Highwire
Aug 201606639pmc
Sep 201645253125Highwire
Sep 201607124pmc
Oct 201671316148Highwire
Oct 201606835pmc
Nov 201644285194Highwire
Nov 201607234pmc
Dec 201633246178Highwire
Dec 201606724pmc
Jan 201735310156Highwire
Jan 201707738pmc
Feb 201748322206Highwire
Feb 201709141pmc
Mar 201786324210Highwire
Mar 201708624pmc
Apr 201758269152Highwire
Apr 2017347787pmc
May 201737256111Highwire
May 2017173946pmc
Jun 201739247142Highwire
Jun 2017254549pmc
Jul 201742228131Highwire
Jul 2017287287pmc
Aug 201744261164Highwire
Aug 2017306271pmc
Sep 201744260156Highwire
Sep 20173994113pmc
Oct 201764320202Highwire
Oct 2017407088pmc
Nov 201740281237Highwire
Nov 20173376101pmc
Dec 2017621071Highwire
Jan 20182127479Highwire
Feb 20181823260Highwire
Mar 20182638589Highwire
Apr 20181353656Highwire
Apr 2018296070pmc
May 20182443081Highwire
Jun 20181436572Highwire
Jun 2018185564pmc
Jul 2018928680Highwire
Aug 2018522059Highwire
Aug 2018286068pmc
Sep 2018826496Highwire
Oct 20181531577Highwire
Nov 20181230867Highwire
Dec 2018630552Highwire
Jan 20193168169Highwire
Feb 20193652566Highwire
Mar 2019823483Highwire
Apr 20191121083Highwire
May 20191125275Highwire
Jun 2019723680Highwire
Jul 2019520963Highwire
Aug 2019923466Highwire
Sep 2019921655Highwire
Oct 20191638480Highwire
Nov 2019423561Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

More Online

CME Course

Topics Discussed

Alert Me